PIII P3 Health Partners Inc. - Class A Common Stock
$10.25
Price · Aug 19, 2026
52W Range
$2–$17
57% of range
Analyst Rating
BUY
8 analysts
Price Target
$18
+76% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
PIII Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$10.25
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$2 – $17
PIII Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
PIII
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
PIII
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
PIII
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
PIII
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
PIII
Peer Median
PIII Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
8 analysts
- Strong Buy 2 25.0%
- Buy 4 50.0%
- Hold 2 25.0%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
2 analysts · 2026-08-19
Median
$18.00
← Below all targets
$10.25
Low
$13.00
High
$23.00
Median target
$18.00
+75.6%
Mean target
$18.00
+75.6%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-3.7%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.63 | $-1.93 | 1.3% |
| March 31, 2026 | $0.32 | $-3.58 | 3.9% |
| Dec. 31, 2025 | $-23.02 | $-9.65 | -13.4% |
| Sept. 30, 2025 | $-9.67 | $-6.16 | -3.5% |
| June 30, 2025 | $-6.23 | $-4.83 | -1.4% |
| March 31, 2025 | $-6.28 | $-9.09 | 2.8% |
| Dec. 31, 2024 | $-19.50 | $-4.18 | -15.3% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| PIII | — | — | — | — | — | — |
| PARK | — | — | — | — | — | — |
| NAKA | $154M | -1.4 | -33.0% | -2867.7% | -20.0% | — |
| DCGO | $87M | -0.5 | -47.7% | -56.6% | -78.5% | — |
| PRPO | $41M | -99.9 | 29.8% | -1.5% | -2.7% | 44.5% |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 23 filers · $2.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 11 (+6 vs prior Q) | 4 (+1 vs prior Q) | 4 (+3 vs prior Q) | 3 (-1 vs prior Q) | +133K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $448,027 | 41,484 | 17.88% | Shares |
| Trinity Financial Advisors LLC | $362,232 | 33,540 | 14.45% | Shares |
| JANE STREET GROUP, LLC | $250,193 | 23,166 | 9.98% | Shares |
| MYDA Advisors LLC | $216,000 | 20,000 | 8.62% | Shares |
| Corient Private Wealth LP | $213,160 | 19,737 | 8.51% | Shares |
| Scientech Research LLC | $176,234 | 16,318 | 7.03% | Shares |
| Abundance Wealth Counselors | $172,800 | 16,000 | 6.90% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $163,609 | 15,149 | 6.53% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $154,782 | 14,330 | 6.18% | Shares |
| DIVERSIFIED TRUST CO | $145,152 | 13,440 | 5.79% | Shares |
| BlackRock, Inc. | $82,480 | 7,637 | 3.29% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $69,952 | 6,477 | 2.79% | Shares |
| VANGUARD GROUP INC | $22,670 | 6,477 | 0.90% | Shares |
| MORGAN STANLEY | $12,118 | 1,122 | 0.48% | Shares |
| Tower Research Capital LLC (TRC) | $5,713 | 529 | 0.23% | Shares |
| Vanguard Global Advisers, LLC | $3,326 | 308 | 0.13% | Shares |
| UBS Group AG | $3,251 | 301 | 0.13% | Shares |
| ROYAL BANK OF CANADA | $3,000 | 296 | 0.12% | Shares |
| HRT FINANCIAL LP | $590 | 54,717 | 0.02% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $389 | 36 | 0.02% | Shares |
| JPMORGAN CHASE & CO | $227 | 19 | 0.01% | Shares |
| PROEQUITIES, INC. | $38 | 200 | 0.00% | Shares |
| Avion Wealth | $0 | 45 | 0.00% | Shares |
Company insiders 17 insiders · 5 officers · 10 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Sherif Abdou | Chief Executive Officer | Aug. 4, 2023 A | 1,608,225 | 0 | 0 | $0 |
| Atul Kavthekar | Chief Financial Officer | Aug. 2, 2023 A | 768,868 | 0 | 0 | $0 |
| Erin Darakjian | Interim CFO, Senior VP & CAO | Nov. 28, 2022 A | — | 0 | 0 | $0 |
| Eric Atkins | Chief Financial Officer | Dec. 3, 2021 A | 450,517 | 0 | 0 | $0 |
| Amir Bacchus | Chief Medical Officer | Aug. 4, 2023 A | 2,005,193 | 0 | 0 | $0 |
| Jeffrey G Park | Director | Aug. 6, 2025 A | 6,331 | 0 | 0 | $0 |
| Gregory D Wasson | Director | Aug. 6, 2025 A | 6,331 | 0 | 0 | $0 |
| Thomas Edmunds Price | Director | March 24, 2022 A | 1,177,659 | 0 | 0 | $0 |
| Lawrence B. Leisure | Director | March 24, 2022 A | — | 0 | 0 | $0 |
| Gregory N. Kazarian | Director | March 24, 2022 A | 471,064 | 0 | 0 | $0 |
| Robert G Zimmerman | Director | Oct. 4, 2021 C | 25,000 | 0 | 0 | $0 |
| Brian R Gamache | Director | Oct. 4, 2021 C | 25,000 | 0 | 0 | $0 |
| John R Svoboda | Director | Oct. 4, 2021 C | 25,000 | 0 | 0 | $0 |
| Foresight Sponsor Group, LLC | 10% owner | Oct. 4, 2021 C | 7,526,025 | 0 | 0 | $0 |
| Michael Balkin | 10% owner | Feb. 12, 2021 P | 7,545,264 | 0 | 0 | $0 |
| Mark Thierer | — | Aug. 6, 2025 A | 12,662 | 0 | 0 | $0 |
| Mary A Tolan | — | Aug. 6, 2025 A | 6,331 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Chicago Pacific Founders UGP, LLC, Chicago Pacific Founders GP, L.P., Chicago Pacific Founders Fund, L.P., Chicago Pacific Founders Fund-A, L.P., Chicago Pacific Founders Fund-B, L.P., VBC Growth SPV, LLC, Chicago Pacific Founders UGP III, LLC, Chicago Pacific Founders GP III, L.P., CPF III PT SPV, LLC, CPF III-A PT SPV, LLC, VBC Growth SPV 3, LLC, VBC Growth SPV 4, LLC ×5 filings | June 6, 2025 | 49.99% | Amendment | — | SEC |
| Leavitt Equity Partners II, L.P., Leavitt Equity Partners II, LLC, Leavitt Equity Partners III, L.P., Leavitt Equity Partners III, LLC, LEP Management, LLC, Leavitt Legacy, LLC, Taylor Leavitt ×3 filings | June 26, 2024 | — | Initial filing | — | SEC |
| NA 2021 GRAT, NA 2021 Trust, NA Charitable Trust, SA 2021 GRAT, SA 2021 Trust, SA Charitable Trust, Abdou Family Trust, Sherif Abdou, M.D., Nahed N. Abdou ×3 filings | Nov. 3, 2023 | — | Initial filing | — | SEC |
| Amir Bacchus, Charlee Co LLC ×3 filings | April 14, 2023 | — | Initial filing | — | SEC |
| Hudson Vegas Investment SPV, LLC, Hudson Vegas Investment Manager, LLC, Straus, Daniel | Dec. 17, 2021 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.